Showing results (151-160 of 276) with videos related to
Sort By:
Pageof 28
Journal of Experimental & Clinical Cancer Research : CR|August 18, 2023
Breast cancer patient-derived microtumors resemble tumor heterogeneity and enable protein-based stratification and functional validation of individualized drug treatmentNicole Anderle, Felix Schäfer-Ruoff, Annette Staebler, et al.Cancers|November 11, 2022
Recurrence Score® Result Impacts Treatment Decisions in Hormone Receptor-Positive, HER2-Negative Patients with Early Breast Cancer in a Real-World Setting-Results of the IRMA TrialDominik Dannehl, Tobias Engler, Lea L Volmer, et al.Cancers|October 2, 2020
Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast CancersAadhya Tiwari, Mari Iida, Corinna Kosnopfel, et al.The Journal of Pathology|December 13, 2019
Interpretation of somatic POLE mutations in endometrial carcinomaAlicia León-Castillo, Heidi Britton, Melissa K McConechy, et al.Breast Cancer Research and Treatment|October 4, 2016
Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancerThomas M Deutsch, Sabine Riethdorf, Juliane Nees, et al.Breast Care (Basel, Switzerland)|November 17, 2025
Overall Survival in Metastatic Breast Cancer Patients: Real-World Data from 1,000 Patients Treated at the NCT Heidelberg between 2014 and 2022Laura L Michel, Manuel Feisst, Verena Thewes, et al.Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|December 3, 2019
Percutaneous Ultrasound-Guided Core Needle Biopsy: Comparison of 16-Gauge versus 14-Gauge Needle and the Effect of Coaxial Guidance in 1065 Breast Biopsies - A Prospective Randomized Clinical Noninferiority TrialInes Gruber, Ernst Oberlechner, Kerstin Heck, et al.Reproduction (Cambridge, England)|March 2, 2017
Hyperandrogenemia and high prolactin in congenital utero-vaginal aplasia patientsPatricia G Oppelt, Andreas Müller, Liana Stephan, et al.Oncotarget|September 9, 2017
Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistryStefan Stefanovic, Ralph Wirtz, Thomas M Deutsch, et al.Gynecologic Oncology|May 20, 2019
Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancerCasper Reijnen, Heidi V N Küsters-Vandevelde, Clemens F Prinsen, et al.Pageof 28